Healthy male/female adults
Conditions
Interventions
Ingestion of the test-food to the volunteers one a day for twelve weeks.
Ingestion of the placebo-food to the volunteers one a day for twelve weeks.
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Male/female Japanese volunteers ranging in age from 55 to 79. (2) Volunteers fully realized that the volunteers themselves must be in forgetfulness, or have been pointed out such tendency. (3) Volunteers having a MMSE-J score of not less than twenty-six. (4) Volunteers who can give informed consent to take part in this research, after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: (1) Volunteers who take steadily (not less than three times a week) in the health-specific/functional/supplementary/health foods, which might affect the test results. (2) Volunteers who have taken affecting medicines (e.g., antibiotic/gut/laxative regulation), and have any difficulty in refraining from taking them during this study. (3) Volunteers being under medical treatment for dyslipidemia, after diagnosis. (4) Volunteers being under medical treatment for dementia, after diagnosis. (5) Volunteers who take excessive alcohol. (6) Volunteers having extremely irregular eating habits, and irregular life rhythms. (7) Volunteers who have a habit of daily vigorous exercises. (8) Volunteers who take not less than fourteen eggs in their daily life. (9) Volunteers who have previous/current medical history of severe cardiac, hepatic, renal or digestive diseases. (10) Pregnant, possibly pregnant, and lactating women. (11) Volunteers having drug and/or food allergy (especially to egg and wheat). (12) Volunteers who are now under another clinical test with some kind of medicine and/or health food, or took part in that within four weeks before this study, or will participate in that after giving informed consent to take part in this study. (13) Volunteers who donated their blood components and/or whole blood (200 mL) within a month to this trial. (14) Volunteers who donated their whole blood (400 mL) within the last three months to this trial. (15) Volunteers who will be collected in total of their blood (1200 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this study. (16) Others who have been determined as ineligible for participation, according to the principal investigator's opinion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitrax basic ver. (Verbal Memory, Visual Memory, Finger Tapping, Symbol Digit Coding, Stroop Test, Shifting Attention, Continuous Performance) | — |
Secondary
| Measure | Time frame |
|---|---|
| Japanese version of the trail making test | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed